• Skip to main content
Go to Healthcare Provider Site
  • Prescribing Information
    • Ferriprox Twice-a-Day Tablets
    • Ferriprox 1000 MG Three-Times-a-Day Tablets
    • Ferriprox 500 MG Three-Times-a-Day Tablets
    • Ferriprox 100 MG/ML Oral Solution 100 MG/ML
  • Disease Information
    • How Iron Loads in the Body
    • Monitoring Targets
  • About Ferriprox
    • Important Information
    • Efficacy
    • Most Common Side Effects
    • Dosing and Formulations
  • MRI T2* Facility Search
  • Your Ferriprox Support Team
  • FAQ
  • Additional Resources
  • APPROVED USES AND IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING

 

Terms of use

The information provided on this Internet Web site (“Site”) is for general informational and educational purposes only. Please read and review these Terms of Use carefully before accessing or using this Site. By accessing or using this Site, you acknowledge that you have read, understood and agreed to these Terms of Use. If you do not agree to the Terms of Use, do not access or use the Site. “Chiesi USA,” as used in these Terms of Use means Chiesi USA, Inc.

1. COPYRIGHT AND TRADEMARK NOTICE

The entire content of this Site is fully protected under all applicable intellectual property laws, including without limitation copyright, trade dress and trademark laws. Users may print copies of the content of this Site for their personal noncommercial use only. Further printing, copying, redistribution or publication of any part of this Site is strictly prohibited, unless expressly permitted as stated within these Terms of Use or as stated within this Site. All trademarks on the Site are registered trademarks of Chiesi USA or one of its affiliated companies unless otherwise noted on the Site.

2. RESTRICTIONS ON USING THE CONTENT OF THIS WEB SITE

Chiesi USA makes no representation regarding the availability, the accuracy, or the completeness of the content of this Site. The Site contains information about products that may or may not be available in a particular country or region of the world, may be available under different trademarks in different countries and, where applicable, may be approved by government regulatory authority for sale or use with different indications and restrictions in different countries.

This Site may contain, from time to time, information related to various health and medical conditions and their treatment. For non-healthcare providers, such information is not intended to be a substitute for the advice provided by a physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. In any event, users of this Site should always consult a doctor and/or other health care professional with respect to health concerns.

While Chiesi USA uses reasonable efforts to include accurate and up-to-date information in its Site, Chiesi USA makes no warranties or representations as to its accuracy. Chiesi USA assumes no liability or responsibility for any errors or omissions in the content of its Site. This Site may provide links or references to other Web sites not affiliated with Chiesi USA. Such links to other Sites are provided only as a convenience to users of this Site. Chiesi USA has not reviewed all of the Sites that may be linked to its Site, and is not responsible for the content of any other Site linked to this Site. Linking to any pages off this Site is at your own risk. Chiesi USA shall not be liable for any damages or injury arising from users access to such Sites.

If in the event the Site provides visitors with an opportunity to post messages, you shall not post or transmit any unlawful, threatening, libelous, defamatory, obscene, inflammatory, pornographic or profane material or material that could constitute or encourage conduct that would be considered a criminal offense, give rise to civil liability, or would otherwise violate the law. Chiesi USA shall not be responsible for content posted to its site by third parties. Chiesi USA respects the privacy of its Site users. Please refer to Chiesi USA’s Privacy Policy which explains how information that is disclosed on this Site will be handled.

3. INDEMNIFICATION BY SITE USER

IN EXCHANGE FOR ACCESSING AND/OR USING THIS SITE, SITE USER AGREES TO INDEMNIFY, DEFEND AND HOLD HARMLESS CHIESI USA, ITS ASSOCIATED COMPANIES, AND ITS AND THEIR, OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, SUPPLIERS AND THIRD PARTY PARTNERS FROM AND AGAINST ALL LOSSES, EXPENSES, DAMAGES AND COSTS, INCLUDING REASONABLE ATTORNEYS’ FEES, RESULTING FROM ANY VIOLATION BY YOU OF THESE TERMS OF USE.

4. LIMITATION OF LIABILITY

Chiesi USA provides the contents of its Site for informational purposes and for your general interest and entertainment only. By using the Site you hereby agree not to rely on any of the information contained herein. UNDER NO CIRCUMSTANCES SHALL CHIESI USA BE LIABLE FOR YOUR RELIANCE ON ANY SUCH INFORMATION NOR SHALL CHIESI USA BE LIABLE FOR DAMAGES OF ANY KIND, INCLUDING, WITHOUT LIMITATION, ANY DIRECT, INCIDENTAL, SPECIAL CONSEQUENTIAL, INDIRECT OR PUNITIVE DAMAGES THAT RESULT FROM THE USE OF, OR THE INABILITY TO USE, THE MATERIALS IN THIS SITE OR THE MATERIALS IN ANY SITE WHICH MAY BE LINKED TO THIS SITE, EVEN IF CHIESI USA OR A CHIESI USA AUTHORIZED REPRESENTATIVE HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. APPLICABLE LAW MAY NOT ALLOW THE LIMITATION OR EXCLUSION OF LIABILITY OR INCIDENTAL OR CONSEQUENTIAL DAMAGES, SO THE ABOVE LIMITATION OR EXCLUSION MAY NOT APPLY TO YOU. IN NO EVENT SHALL CHIESI USAS TOTAL LIABILITY TO YOU FOR ALL DAMAGES, LOSSES, AND CAUSES OF ACTION WHETHER THE CAUSE OF ACTION IS IN CONTRACT, TORT (INCLUDING, BUT NOT LIMITED TO, NEGLIGENCE) OR OTHERWISE EXCEED THE AMOUNT PAID BY YOU, IF ANY, FOR ACCESSING THIS SITE.

5. DISCLAIMER OF WARRANTIES

THE MATERIALS IN THIS SITE ARE PROVIDED “AS IS” AND WITHOUT WARRANTIES OF ANY KIND EITHER EXPRESS OR IMPLIED. TO THE FULLEST EXTENT PERMISSIBLE PURSUANT TO APPLICABLE LAW, CHIESI USA DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. CHIESI USA DOES NOT WARRANT THAT THE FUNCTIONS CONTAINED IN THE MATERIALS WILL BE UNINTERRUPTED OR ERROR-FREE, THAT DEFECTS WILL BE CORRECTED, OR THAT THIS SITE OR THE SERVER THAT MAKES IT AVAILABLE ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. CHIESI USA DOES NOT WARRANT OR MAKE ANY REPRESENTATIONS REGARDING THE USE OR THE RESULTS OF THE USE OF THE MATERIALS IN THESE SITES IN TERMS OF THEIR CORRECTNESS, ACCURACY, RELIABILITY, OR OTHERWISE. YOU (AND NOT CHIESI USA) ASSUME THE ENTIRE COST OF ALL NECESSARY SERVICING, REPAIR OR CORRECTION. APPLICABLE LAW MAY NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO THE ABOVE EXCLUSION MAY NOT APPLY TO YOU.

6. JURISDICTIONAL ISSUES/EXPORT RESTRICTIONS

This Site is controlled and operated by Chiesi USA from its offices within the State of North Carolina, United States of America. Although the Internet is global in nature, the laws regulating the manner in which pharmaceutical companies convey medical or product information is not. Each country has its own set of rules, regulations and laws. As a result, information intended for dissemination in a particular country may not be appropriate for use outside that country. The information on this Site is designed to comply with the laws of the United States. The information on this Site is intended for access and use by U.S. residents only. These Terms of Use shall be governed by and construed in accordance with the laws of the State of North Carolina, without giving effect to any principles of conflicts of law. If any provision of these Terms of Use shall be unlawful, void, or for any reason unenforceable, then that provision shall be deemed severable from these Terms of Use and shall not affect the validity and enforceability of any remaining provisions. This is the entire Agreement between the parties relating to the subject matter herein.

This Site may link to other Sites produced by companies related to Chiesi USA, some of which are outside the U.S. Those Sites may have information that is appropriate only to the particular originating country or region where the Site is based. You should not construe anything on the Site as a promotion or solicitation for any product or for the use of any product that is not authorized by the laws and regulations of the country where you are located. Chiesi USA makes no representation that materials in the Site are appropriate or available for use in other locations. Those who choose to access this Site from other locations do so on their own initiative and are responsible for compliance with local laws, if and to the extent local laws are applicable.

Software from this Site is further subject to United States export controls. No software from this Site may be downloaded or otherwise exported or re-exported (i) into (or to a national or resident of) Cuba, Iraq, Libya, North Korea, Iran, Syria or any other country subject to United States export control restrictions; or (ii) to anyone on the U.S. Treasury Department’s list of Specially Designated Nationals or the U.S. Commerce Department’s Table of Denial Orders. By downloading or using the Software, you represent and warrant that you are not located in, under the control of, or a national or resident of any such country or on any such list.

7. PRIVACY

Under no circumstances, should you use this Site or any of the fax and mailing addresses on the Site to send Chiesi USA confidential or proprietary information. Chiesi USA does not want to receive such confidential or proprietary information. Any information deemed not personally identifiable and deemed not subject to our Privacy Policy, including questions, comments, ideas, and suggestions shall be deemed to be non-confidential, and Chiesi USA shall be free to disclose and/or use the same, without obligations whatsoever towards you, for any purpose whatsoever and through any means whatsoever.

8. LINKING POLICY

  1. Links Out — This Site may provide links or references to other Web sites not affiliated with Chiesi USA. Chiesi USA has not reviewed the content of Web sites that may be linked to its Site, makes no representations about the content of the Web sites, and is not responsible for the content of any other Web site linked to this Site. Linking to any pages off this Site is at your own risk. Chiesi USA shall not be liable for any damages or injury arising from users’ access to such Web sites.
  2. Links In — Unless otherwise set forth in a written agreement between you and Chiesi USA, you must adhere to Chiesi USA’s linking policy as follows: i) any link to a Chiesi USA Site must be a text only link clearly marked with the name of the specific Chiesi USA Web site, ii) the appearance, position and other aspects of the link may not be such as to damage or dilute the goodwill associated with Chiesi USA’s name or trademarks, iii) the link must point to one of the specific Chiesi USA Web site URLs homepage and not to other pages within the Web site, iv) the appearance, position and other attributes of the link may not create the false appearance that your organization or entity is sponsored by, associated with, or affiliated with Chiesi USA or the Site, v) when selected by the user, the link must display the Web site on full screen and not within a “frame” on the linking Website, and vi) the linked Web site must comply with all applicable U.S. laws, rules, and regulations. Chiesi USA shall not be liable for any damages or injury arising from such Links In any Chiesi USA Site.

 

What is Ferriprox® (deferiprone)?

Ferriprox is a prescription medicine used to treat people with thalassemia syndromes who have iron overload from blood transfusions when current iron removal (chelation) therapy does not work well enough.

What is the most important information I should know about Ferriprox? Approval is based on a reduction in serum ferritin levels. There are no controlled trials demonstrating a direct treatment benefit, such as improvement in disease-related symptoms, functioning, or increased survival.

It is not known if Ferriprox is safe and effective to treat iron overload due to blood transfusions in people with any other type of anemia that is long lasting (chronic) or in children.
 

Important Safety Information

What is the most important information I should know about Ferriprox?

Ferriprox can cause serious side effects, including a very low white blood cell count. One type of white blood cell that is important for fighting infections is called a neutrophil. If your neutrophil count is low (neutropenia), you may be at risk of developing a serious infection that can lead to death. Neutropenia is common with Ferriprox and can become severe in some people. Severe neutropenia is known as agranulocytosis. If you develop agranulocytosis, you will be at risk of developing serious infections that can lead to death.

Your healthcare provider should do a blood test before you start Ferriprox and weekly during treatment to check your neutrophil count. If you develop neutropenia, your healthcare provider should check your blood counts every day until your white blood cell count improves. Your healthcare provider may temporarily stop treatment with Ferriprox if you develop neutropenia or infection.

Stop taking Ferriprox and get medical help right away if you develop any of these symptoms of infection: fever, sore throat or mouth sores, flu-like symptoms, or chills and severe shaking.

Do not take Ferriprox if you are allergic to deferiprone or any of the ingredients in Ferriprox.

Before you take Ferriprox, tell your healthcare provider about all of your medical conditions, including if you: have liver problems, are pregnant or plan to become pregnant. Ferriprox can harm your unborn baby. You should avoid becoming pregnant during treatment with Ferriprox. Tell your healthcare provider right away if you become pregnant during treatment with Ferriprox. For females who are able to become pregnant, your healthcare provider should do a pregnancy test before you start treatment with Ferriprox. You should use effective birth control during treatment with Ferriprox and for at least 6 months after the last dose. For males with female partners who are able to become pregnant, you should use effective birth control during treatment with Ferriprox and for at least 3 months after the last dose. Talk to your doctor if you are breastfeeding or plan to breastfeed. It is not known if Ferriprox passes into your breast milk. Do not breastfeed during treatment with Ferriprox and for at least 2 weeks after the last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

Avoid drinking alcohol during treatment with Ferriprox tablets (2 times a day). This may cause a faster release of the medicine.

What are other possible side effects of Ferriprox?

Ferriprox can cause serious side effects, including increased liver enzyme levels in your blood. Your healthcare provider should do monthly blood tests to check your liver function during treatment with Ferriprox.

Ferriprox can cause decreased levels of zinc in your blood. Your healthcare provider will do blood tests to check your zinc levels during treatment with Ferriprox and may prescribe a zinc supplement for you if your zinc levels are low.

Ferriprox may cause a change in urine color to reddish-brown. This is not harmful and is expected during treatment with Ferriprox.

The most common side effects of Ferriprox include nausea, vomiting, stomach- area (abdominal) pain, and joint pain.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
 

Please see full Prescribing Information, including boxed WARNING, and Medication Guide.

 

References:

  1. Ferriprox® (deferiprone) Prescribing Information. Chiesi, May 2020.
  2. Data on file.
  3. United Kingdom Thalassaemia Society. Standards for the Clinical Care of Children and Adults with Thalassaemia in the UK. 3rd edition; 2016. Editors Yardumian A, Telfer P, Shah F, et al. Available online at: https://ukts.org/wp-content/uploads/2019/12/Standards-2016final.pdf.
  4. Noetzil LJ, et al. Longitudinal analysis of heart and liver iron in thalassemia major. Blood 2008;112(7):2973-2978.
  5. Modell B, Khan M, Darlison M, et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008;10(42). doi:10.1186/1532- 429X-10-42.
  6. Standards of care guidelines for thalassemia. Children’s Hospital & Research Center Oakland, 2012. Available online at: https://thalassemia.com/documents/SOCGuidelines2012.pdf.
  7. Pennell DJ, et al. Cardiovascular function and treatment in ß-thalassemia major: a consensus statement from the American Heart Association. Circulation 2013;128(3):281-308.
  8. Thalassaemia International Federation. Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT). 3rd edition. Nicosia (CY): Thalassaemia International Federation, 2014. Editors Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V. Available online at: http://www.ncbi.nlm.nih.gov/ books/NBK269382/.
  9. Sheth S. Monitoring of iron overload in transfusion-dependent thalassemia (TDT). Cooley’s Anemia Foundation. Accessed online October 10, 2019 at: https://thalassemia.com/documents/monitoring-iron- overload-in-transfusion-dependent-thalassemia.pdf.
  10. Jamuar, S and Lai, AHM. Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia. Ther Adv Hematol 2012;3(5):299-307.
  11. Binding A, et al. Deferiprone exerts a dose-dependent reduction of liver iron in adults with iron overload. Eur J Haematol 2019;103(2):80-87.
  12. Ferriprox® (deferiprone) Prescribing Information. Chiesi, April 2020.

 

©Chiesi USA, Inc. 2020. All rights reserved.
Ferriprox® is a registered trademark of CHIESI FARMACEUTICI S.p.A.
Chiesi Total CareSM is a service mark of CHIESI FARMACEUTICI S.p.A.
PP-G-0376 V3.0 November 2020

Privacy PolicyTerms of Use

You are now leaving ferriprox.com

Please be aware that the sponsors of this site are not responsible for content on the site you are about to enter.